Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KAJINUMA H")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1
Export

Selection :

  • and

EFFECT OF ALPHA ADRENORECEPTOR STIMULANTS INFUSED INTRAPANCREATICALLY ON GLUCAGON AND INSULIN SECRETION.KANETO A; KAJINUMA H; KOSAKA K et al.1977; HORMONE METABOL. RES.; GERM.; DA. 1977; VOL. 9; NO 4; PP. 267-271; BIBL. 14 REF.Article

EFFECT OF SPLANCHNIC NERVE STIMULATION ON GLUCAGON AND INSULIN OUTPUT IN THE DOG = EFFET DE LA STIMULATION DU NERF SPLANCHNIQUE SUR LA DECHARGE DE GLUCAGON ET D'INSULINE CHEZ LE CHIENKANETO A; KAJINUMA H; KOSAKA K et al.1975; ENDOCRINOLOGY; U.S.A.; DA. 1975; VOL. 96; NO 1; PP. 143-150; BIBL. 34 REF.Article

DEGRADATION AND SECRETION OF INSULIN IN HEPATIC CIRRHOSISIWASAKI Y; OHKUBO A; KAJINUMA H et al.1978; J. CLIN. ENDOCRINOL. 8METABOL.; USA; DA. 1978; VOL. 47; NO 4; PP. 774-779; BIBL. 26 REF.Article

EFFECT OF BOMBESIN INFUSED INTRAPANCREATICALLY ON GLUCAGON AND INSULIN SECRETION.KANETO A; KANEKO T; NAKAYA S et al.1978; METABOLISM; USA; DA. 1978; VOL. 27; NO 5; PP. 549-553; BIBL. 28 REF.Article

EFFECT OF PHENTOLAMINE ON THE SOMATOSTATIN-INDUCED INHIBITION OF GLUCAGON AND INSULIN SECRETIONKANETO A; KAJINUMA H; KANEKO T et al.1978; METABOLISM; USA; DA. 1978; VOL. 27; NO 8; PP. 901-910; BIBL. 55 REF.Article

EFFECT OF VASOACTIVE INTESTINAL POLYPEPTIDE INFUSED INTRAPANCREATICALLY ON GLUCAGON AND INSULIN SECRETION.KANEKO A; KANEKO T; KAJINUMA H et al.1977; METABOLISM; U.S.A.; DA. 1977; VOL. 26; NO 7; PP. 781-786; BIBL. 25 REF.Article

GLUCAGON SECRETION OF THE PANCREATIC ALLOGRAFT IN THE DOG = SECRETION DE GLUCAGON PAR LE PANCREAS ALLOGREFFE CHEZ LE CHIENIDEZUKI Y; MAKI T; KABAYA T et al.1972; SURG. FORUM,; U.S.A.; DA. 1972; VOL. 23; PP. 373-375; BIBL. 3REF.Serial Issue

Evaluation and clinical applications of measurement of urinary growth hormone in diabetic subjectsSUZUKI, K; MIYATA, H; SUZUKI, T et al.Diabetes (New York, NY). 1989, Vol 38, Num 12, pp 1567-1572, issn 0012-1797Article

Adrenalectomy-induced alterations in glucagon binding and lipolysis in isolated rat adipocytesWATANABE, K; IRIE, M; KAJINUMA, H et al.Hormone and metabolic research. 1990, Vol 22, Num 4, pp 215-220, issn 0018-5043Article

HUMAN PLASMA C-PEPTIDE IMMUNOREACTIVITY: ITS CORRELATION WITH IMMUNOREACTIVE INSULIN IN DIABETES, AND CHRONIC LIVER AND RENAL DISEASESKAJINUMA H; KANAZAWA Y; SANDO H et al.1979; ENDOCRINOL. JAP.; JPN; DA. 1979; VOL. 26; NO 1; PP. 65-73; BIBL. 23 REF.Article

Glucagon inhibits insulin activation of glucose transport in rat adipocytes mainly through a postbinding processSATO, N; IRIE, M; KAJINUMA, H et al.Endocrinology (Philadelphia). 1990, Vol 127, Num 3, pp 1072-1077, issn 0013-7227, 6 p.Article

COMPARISON OF THE EARLY TIME COURSES OF THE RELEASE OF INSULIN THAT FOLLOW INJECTIONS OF TETRAGASTRIN, TOLBUTAMIDE, XYLITOL, AND GLUCOSE INTO THE PANCREATIC ARTERY OF DOGSKUZUYA T; KAJINUMA H; SANDO H et al.1978; DIABETES; USA; DA. 1978; VOL. 27; NO 12; PP. 1189-1195; BIBL. 16 REF.Article

SUSTAINED HYPOGLYCEMIN IN RESPONSE TO INTRAVENOUS INFUSION OF D-RIBOSE IN NORMAL DOGS.ISHIWATA K; KUZUYA N; KAJINUMA H et al.1978; ENDOCRINOL. JAP.; JPN; DA. 1978; VOL. 25; NO 2; PP. 163-169; BIBL. 19 REF.Article

DEMONSTRATION OF ANTI-"A-COMPONENT" ANTIBODY. A POSSIBLE MEANS TO DIFFERENTIATE PATIENTS WITH AUTO-ANTIBODIES TO ENDOGENOUS INSULIN FROM INSULIN-TREATED PATIENTS. = MISE EN EVIDENCE D'UN ANTICORPS ANTI-COMPOSE A. UN MOYEN EVENTUEL DE DISTINCTION DES PATIENTS AYANT DES AUTO-ANTICORPS ANTI-INSULINE ENDOGENE DE CEUX TRAITES PAR INSULINEKAWAZU S; KANAZAWA Y; KAJINUMA H et al.1975; DIABETOLOGIA; ALLEM.; DA. 1975; VOL. 11; NO 3; PP. 169-173; BIBL. 15 REF.Article

Characteristics of crainal nerve palsies in diabetes patientsWATANABE, K; HAGURA, R; AKANUMA, Y et al.Diabetes research and clinical practice. 1990, Vol 10, Num 1, pp 19-27, issn 0168-8227, 9 p.Article

Serum gliclazide concentration in diabetic patients. Relationship between gliclazide dose and serum concentrationSHIBA, T; KAJINUMA, H; SUZUKI, K et al.Diabetes research and clinical practice. 1986, Vol 2, Num 5, pp 301-306, issn 0168-8227Article

A pilot clinical trial of a new oral hypoglycemic agent, CS-045, in patients with non-insulin dependent diabetes mellitusKUZUYA, T; IWAMOTO, Y; BABA, S et al.Diabetes research and clinical practice. 1991, Vol 11, Num 3, pp 147-153, issn 0168-8227, 7 p.Article

  • Page / 1